Home » Topics » Regulatory » NMPA

NMPA
RSS

UC MSCs show potential in clinical study for SLE

July 30, 2014

China's regulatory authority approves phase II trials of F-351

July 3, 2014

Chinese fast track designation granted to epilepsy drug DP-VPA

June 11, 2014

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical obtains Chinese clinical trial clearance

May 22, 2014

Sihuan Pharmaceutical's application for clinical trial approval for pirotinib accepted in China

Oct. 14, 2013

Lee's Pharmaceutical submits CTA to expand the APEX study to China

Aug. 29, 2013

Lee's Pharmaceutical files to perform pivotal trial of gimatecan for ovarian cancer in China

Aug. 8, 2013

Takeda receives marketing authorization in China for Nesina

Aug. 2, 2013

Beijing Drug Administration accepts Sinovac's filing for EV71 vaccine candidate

May 31, 2013

Sihuan Pharmaceutical cleared to conduct study of DPP IV inhibitor in China

Feb. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...